Zhao et al. showed that the IDO enzyme activity in TAMs of the hepatocellular carcinoma tissue is being boosted by CD69+ T cells, in which CD69 is expressed on early-activated T cells within the TME [104]. The gene discussed is CD69; the disease is hepatocellular carcinoma.